Suche
Ihre Suche nach "%2A" ergab 95 Treffer
×
Johannes Gutenberg-Universität Mainz
- Mauss, S.; Boeker, K. H. W.; Eisenbach, C. et al.
- REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY
- JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S357-S358
- Zimmermann, Tim; Hueppe, Dietrich; Mauss, Stefan et al.
- Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naive Patients Infected with Hepatitis C Virus Genotype 1
- JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. Bd. 25. H. 1. 2016 S. 15-24
- Christensen, S.; Mauss, S.; Eisenbach, C. et al.
- WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS
- JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S329-S329
- Boeker, K; Mauss, S; Hueppe, D et al.
- Dose Reduction of Peginterferon Alfa-2a (PEG) in Combination With Ribavirin (RBV) in Chronic Hepatitis C (CHC) Patients: Impact on Virological Response Under Real Life Conditions
- GASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S948-S948
- Boeker, K; Mauss, S; Hueppe, D et al.
- DOSE REDUCTION OF PEGINTERFERON ALFA-2A (PEG) IN COMBINATION WITH RIBAVIRIN (RBV) IN CHRONIC HEPATITIS C (CHC) PATIENTS: IMPACT ON VIROLOGICAL RESPONSE UNDER REAL LIFE CONDITIONS
- JOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S162-S162
- Zehnter, E; Hueppe, D; Kaiser, S et al.
- ROLE OF RVR AND VIRAL LOAD ON SVR IN TREATMENT OF GT3 HEPATITIS C PATIENTS WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE
- JOURNAL OF HEPATOLOGY. Bd. 50. 2009 S. S239-S240
- Zeuzem, S; Arora, S; Bacon, B et al.
- PEGINTERFERON LAMBDA-1A (LAMBDA) COMPARED TO PEGINTERFERON ALFA-2A (ALFA) IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPES (G) 2 OR 3: FIRST SVR24 RESULTS FROM EMERGE PHASE IIB
- JOURNAL OF HEPATOLOGY. Bd. 56. 2012 S. S5-S6
- Moreno, Christophe; Ferenci, Peter; Asselah, Tarik et al.
- Faldaprevir Plus Pegylated Interferon Alfa-2a and Ribavirin in Chronic HCV Genotype-1 Treatment-Naive Patients: Final Results from STARTVerso1: A Randomized, Double-blind, Placebo-Controlled, Phase 3 Trial
- AMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 108. 2013 S. S145-S145
- Sprinzl, Martin; Grambihler, Annette; Teuber, Gerlinde et al.
- Predictors of treatment response during addition of pegylated Interferon alfa-2a to an onging nucleos (t)id treatment in chronic hepatitis B: Results from the PADD-ON trial
- JOURNAL OF HEPATOLOGY. Bd. 70. 2019 S. E485-E485
- Dieterich, D; Asselah, T; Guyader, D et al.
- SILEN-C3: TREATMENT FOR 12 OR 24 WEEKS WITH BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAiVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION
- HEPATOLOGY. Bd. 54. 2011 S. 378A-378A